Erector Spinae Plane Block for Postoperative Analgesia for Laparoscopic Cholecystectomy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03420703 |
|
Recruitment Status :
Completed
First Posted : February 5, 2018
Last Update Posted : June 15, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Postoperative Pain | Other: erector spinae plane block Device: Intravenous morphine patient controlled analgesia device | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 46 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | The Effect of Erector Spinae Plane Block on Postoperative Pain Following Laparoscopic Cholecystectomy: A Randomized Controlled Study |
| Actual Study Start Date : | February 24, 2018 |
| Actual Primary Completion Date : | April 18, 2018 |
| Actual Study Completion Date : | April 18, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Block group
Erector espine plane block will be administrated to this group. An intravenous patient controlled analgesia device will be given to the patients postoperatively
|
Other: erector spinae plane block
ultrasound guided erector spinae plane block will be administered to this group. Device: Intravenous morphine patient controlled analgesia device Intravenous morphine patient controlled analgesia device will be given to the patients postoperatively and 24 hour morphine consumption will be recorded |
|
Sham Comparator: control group
An intravenous patient controlled analgesia device will be given to the patients postoperatively
|
Device: Intravenous morphine patient controlled analgesia device
Intravenous morphine patient controlled analgesia device will be given to the patients postoperatively and 24 hour morphine consumption will be recorded |
- 24h morphine consumption [ Time Frame: for postoperative 24 hour ]morphine consumptions for both group will be recorded
- Postoperative nausea and vomiting [ Time Frame: 24 hour ]PONV after surgery was questioned
- Pain [ Time Frame: 24h ]Numeric rating scales were recorded
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 25 - 75 years of age
- ASA I - II
- Undergoing elective laparoscopic cholecystectomy
Exclusion Criteria:
- obesity
- ASA III - IV
- infection of the skin at the site of needle puncture area
- patients with known allergies to any of the study drugs
- coagulopathy
- recent use of analgesic drugs
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03420703
| Turkey | |
| Kocaeli University Hospital | |
| İzmit, Kocaeli, Turkey, 41340 | |
| Responsible Party: | Can AKSU, Assistant Professor, Kocaeli University |
| ClinicalTrials.gov Identifier: | NCT03420703 |
| Other Study ID Numbers: |
2017-349 |
| First Posted: | February 5, 2018 Key Record Dates |
| Last Update Posted: | June 15, 2018 |
| Last Verified: | June 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
erector spinae plane block laparoscopic cholecystectomy postoperative pain |
|
Pain, Postoperative Postoperative Complications Pathologic Processes Pain Neurologic Manifestations Morphine Analgesics, Opioid |
Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents |

